Scientists at Google DeepMind —the company’s artificial intelligence research arm—say they’ve created an A.I. tool that can ...

AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely ...

Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...

The trial is funded through Abu Dhabi's Healthcare Research and Innovation FundClinical development activities will commence at Cleveland Clinic Abu Dhabi in 2026MERTK-related retinitis pigmentosa aff ...

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced a series of key senior ...

Jordan Marx does not remember a time when sheep were not part of his daily life. As a kid, he showed lambs competitively at ...

Patients reveal persistent gaps in genetic testing, diagnosis, and clinical trial access—and implications for advancing ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ('the Company', 'Kraig Labs', or 'Kraig's'), a world leader in spider silk technology*, today announced that it is entering the new year with the ...

Whenever an animal species drops into the single digits, every risk to them matters. While not necessarily a common ...

Alyssa Katz has been named Editor-in-Chief of the Forward, the nation’s most influential and widely read Jewish publication. The appointment was announced today by Forward Publisher & CEO Rachel ...

Friedreich’s ataxia (FA) is a rare but devastating genetic disorder. Those with the condition are often diagnosed between 5 and 15 years of age and live only into their 30s or 40s. There is no widely ...

A couple with deep ties to the Chicago area is donating $11 million to Lurie Children’s Hospital in hopes of speeding research, treatment and diagnosis for children with rare and genetic disorders.